跳至主要内容
临床试验/EUCTR2005-004714-32-IT
EUCTR2005-004714-32-IT进行中(未招募)不适用

A PHASE II, MULTI-CENTER STUDY OF BORTEZOMIB, ADRIAMYCIN, DEXAMETHASONE (PAD) as induction and MELPHALAN 100 mg/m2 (MEL 100) as transplant, IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

FONDAZIONE NEOPLASIE SANGUE ONLUS0 个研究点开始时间: 2007年12月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
FONDAZIONE NEOPLASIE SANGUE ONLUS

相似试验

进行中(未招募)
不适用
A PHASE II MULTICENTER STUDY OF BORTEZOMIB, THALIDOMIDE, PEGHILATED LIPOSOMAL DOXORUBICIN, DEXAMETHASONE (ThaDD-V)IN PATIENTS AFFECTED BY RELAPSED-REFRACTORY MULTIPLE MYELOMA - ND
EUCTR2006-002564-25-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
进行中(未招募)
1 期
A study in which is investigated if the medicine bortezomib is effective in patients with AL amyloidosis
EUCTR2010-021445-42-NLHOVON Foundation50
进行中(未招募)
不适用
PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY. - NDWALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMAMedDRA version: 9.1Level: LLTClassification code 10003908Term: B-cell small lymphocytic lymphoma
EUCTR2006-003495-35-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中(未招募)
1 期
A study in which is investigated if the medicine bortezomib is effective in patietns with AL amylodosis.AL AmyloidosisMedDRA version: 20.0Level: PTClassification code 10002022Term: AmyloidosisSystem Organ Class: 10021428 - Immune system disorders
EUCTR2010-021445-42-BEHOVON Foundation50
进行中(未招募)
不适用
A PHASE II STUDY OF VELCADE BORTEZOMIB - PS341 IN THE TREATMENT OF PATIENTS OVER 18 YEARS WITH Ph LEUKEMIApatients over 18 years with Ph leukaemiaMedDRA version: 9.1Level: LLTClassification code 10009013Term: Chronic myeloid leukaemia
EUCTR2004-002977-22-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
A PHASE II, MULTI-CENTER STUDY OF BORTEZOMIB,... | 临床试验